Abstract
The predictive value of human immunodeficiency virus type 1 (HIV-1) RNA detection in plasma using branched DNA assay was studied in a subgroup of 36 asymptomatic HIV-1-infected patients enrolled in a multicenter, double-blind, randomized study. Patients were randomized to receive either zidovudine (AZT) 1 g/day or placebo and were monitored for a mean time of 61 months. HIV-1 RNA was detected in plasma using branched DNA assay at months 0, 6, 12, 24, and 36. HIV-1 RNA was detected at levels of ≥ 104 RNA eq/ml (eq/ml) in 8.3% of the patients at baseline, and this percentage increased during the first two years in the placebo group only. The detection rate of HIV-1 RNA at three years was 50% in both the AZT and the placebo groups. HIV-1 RNA levels ranged from 104 to 478 × 103 RNA eq/ml. HIV-1 RNA was detected at levels of > 104 eq/ml a mean time of 19±13 months before progression to AIDS in 76.5% of progressing patients. In a multivariate analysis including baseline CD4+ count, the initial randomization group, HIV-1 RNA detection in plasma, and detection of p24 antigenemia during the first three years of follow-up, the best independent predictors of progression to AIDS at five years and the best independent predictors of death at five years were HIV-1 RNA detection in plasma and p24 antigenemia.
Similar content being viewed by others
References
Schnittman SM, Greenhouse JJ, Psallidopoulos MC, Baseler M, Salzman NP, Fauci AS, Clifford Lane H: Increasing viral burden in CD4+ cells in HIV-1 reflects rapidly progressive immunosuppression and clinical disease. Annals of Internal Medicine 1990, 113: 438–443.
Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362: 359–362.
Gupta P, Kingsley L, Armstrong J, Ding M, Cotrill M, Rinaldo C: Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 1993, 196: 586–595.
Montoya JG, Wood R, Katzenstein D, Holodny M, Merigan T: Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect. Journal of Clinical Microbiology 1993, 31: 2692–2696.
Pantaleo G, Graziosi C, Desmarets JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362: 355–358.
Ho DD, Moudgil T, Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. New England Journal of Medicine 1989, 321: 1621–1625.
Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L: Plasma viremia in human immunodeficiency virus infection. New England Journal of Medicine 1989, 321: 1626–1631.
Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S: Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. Journal of Clinical Microbiology 1994, 32: 292–300.
Van Gemen B, Kievits T, Schukkink R, Van Strijp D, Malek LT, Sooknanan R, Huisman HG, Lens P: Quantitation of HIV-1 RNA in plasma using NASBATM during HIV-1 primary infection. Journal of Virological Methods 1993, 43: 177–188.
Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong SJ, Stempien M, Hoo B, Besemer D, Yeghiazarian T, Irvine B, Kolberg J, Kokka R, Neuwald P, Urdea MS: Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995, 8: 446–454.
Urdea MS, Wilber JC, Yeghiazarian T, Todd JA, Kern DG, Fong SJ, Besemer D, Hoo B, Sheridan PJ, Kokka R, Neuwald P, Pachl CA: Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 1993, 7, Supplement 2: 11–14.
Dewar RL, Highbarger HC, Sarmiento MD, Todd JA, Vasudevachari MB, Davey RT Jr, Kovacs JA, Salzman NP, Clifford Lane H, Urdea MS: Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. Journal of Infectious Diseases 1994, 170: 1172–1179.
Todd J, Pachi C, White R, Yeghiazarian T, Johnson P, Taylor B, Holodniy M, Kern D, Hamren S, Chernoff D, Urdea M: Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995, 10, Supplement 2: 35–44.
Cao Y, Ho DD, Todd J, Kokka R, Urdea M, Lifson JD, Piatak M Jr, Chen S, Hahn BH, Saag MS, Shaw GM: Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Research and Human Retrovirus 1995, 11: 353–361.
Concorde Coordinating Committee: Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994, 343: 871–881.
Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 1987, 36, Supplement 1S: 1–15.
Mellors JW, Lawrence AK, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Annals of Internal Medicine 1995, 122: 573–579.
Choi S, Lagakos SW, Schooley RT, Volberding PA: CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection. Annals of Internal Medicine 1993, 118: 674–680.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cotte, L., Trabaud, M.A., Rougier, P. et al. Predictive value of HIV-1 RNA detection in plasma by branched DNA assay during long-term zidovudine therapy. Eur. J. Clin. Microbiol. Infect. Dis. 15, 639–645 (1996). https://doi.org/10.1007/BF01691149
Issue Date:
DOI: https://doi.org/10.1007/BF01691149